Literature DB >> 11722579

Identification of molecular determinants required for interaction of ubiquitin-conjugating enzymes and RING finger proteins.

G Martinez-Noel1, U Müller, K Harbers.   

Abstract

Recent results from several laboratories suggest that the interaction of E2 ubiquitin-conjugating enzymes with the RING finger domain has a central role in mediating the transfer of ubiquitin to proteins. Here we present a mutational analysis of the interaction between the E2 enzyme UbcM4/UbcH7 and three different RING finger proteins, termed UIPs, which, like Parkin, contain a RING1-IBR-RING2 motif. The results show that the E2 enzyme binds to the RING1 domain but not to the other cysteine/histidine-rich domains of the RING1-IBR-RING2 motif. Three regions within the UbcM4 molecule are involved in this interaction: the H1 alpha helix, loop L1, connecting the third and fourth strand of the beta sheet, and loop L2, located between the fourth beta strand and the second alpha helix. Loop L2 plays an important role in determining the specificity of interaction. The effects of L2 mutations on UbcM4/UIP interaction are different for each UIP, indicating that RING finger domains can vary considerably in their structural requirements for binding to E2 enzymes. The result that single amino-acid changes can regulate binding of E2 enzymes to different RING finger proteins suggests a novel approach to experimentally manipulate proteolytic pathways mediated by RING finger proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722579     DOI: 10.1046/j.0014-2956.2001.02541.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.

Authors:  Peter S Brzovic; Jennifer R Keeffe; Hiroyuki Nishikawa; Keiko Miyamoto; David Fox; Mamoru Fukuda; Tomohiko Ohta; Rachel Klevit
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

2.  Sequence determinants of E2-E6AP binding affinity and specificity.

Authors:  Ziad M Eletr; Brian Kuhlman
Journal:  J Mol Biol       Date:  2007-03-19       Impact factor: 5.469

Review 3.  RBR E3-ligases at work.

Authors:  Judith J Smit; Titia K Sixma
Journal:  EMBO Rep       Date:  2014-01-27       Impact factor: 8.807

4.  Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.

Authors:  Selvaraju Veeriah; Barry S Taylor; Shasha Meng; Fang Fang; Emrullah Yilmaz; Igor Vivanco; Manickam Janakiraman; Nikolaus Schultz; Aphrothiti J Hanrahan; William Pao; Marc Ladanyi; Chris Sander; Adriana Heguy; Eric C Holland; Philip B Paty; Paul S Mischel; Linda Liau; Timothy F Cloughesy; Ingo K Mellinghoff; David B Solit; Timothy A Chan
Journal:  Nat Genet       Date:  2009-11-29       Impact factor: 38.330

Review 5.  Building ubiquitin chains: E2 enzymes at work.

Authors:  Yihong Ye; Michael Rape
Journal:  Nat Rev Mol Cell Biol       Date:  2009-11       Impact factor: 94.444

6.  RNF144A, an E3 ubiquitin ligase for DNA-PKcs, promotes apoptosis during DNA damage.

Authors:  Shiuh-Rong Ho; Christina S Mahanic; Yu-Ju Lee; Weei-Chin Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

7.  Loop 7 of E2 enzymes: an ancestral conserved functional motif involved in the E2-mediated steps of the ubiquitination cascade.

Authors:  Elena Papaleo; Nicola Casiraghi; Alberto Arrigoni; Marco Vanoni; Paola Coccetti; Luca De Gioia
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

8.  What was the set of ubiquitin and ubiquitin-like conjugating enzymes in the eukaryote common ancestor?

Authors:  Caroline Michelle; Patrick Vourc'h; Laurence Mignon; Christian R Andres
Journal:  J Mol Evol       Date:  2009-05-19       Impact factor: 2.395

Review 9.  RBR E3 ubiquitin ligases: new structures, new insights, new questions.

Authors:  Donald E Spratt; Helen Walden; Gary S Shaw
Journal:  Biochem J       Date:  2014-03-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.